A Pharmacokinetic And Wearability Study of the Agile TCDS AG200-15 Following Weekly Application Under Various External Conditions in Healthy Female Volunteers.
Phase of Trial: Phase I
Latest Information Update: 28 Dec 2017
At a glance
- Drugs Ethinylestradiol/levonorgestrel (Primary)
- Indications Pregnancy
- Focus Pharmacokinetics
- Sponsors Agile Therapeutics
- 07 May 2012 Results have been presented at the American College of Obstetricians and Gynecologists' 60th Annual Clinical Meeting.
- 07 May 2012 Primary endpoint 'Pharmacokinetic-parameters' has been met.
- 05 May 2012 Results presented at the 60th Annual Clinical Meeting of the American College of Obstetricians and Gynecologists.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History